Peirce Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Peirce Capital Management's LLY Position: Q3 2026 in Review
Peirce Capital Management increased its Eli Lilly (LLY) stake by 7.2% in Q3 2026, buying an estimated $34.2K and bringing the position to 432 shares worth $500K. The position accounts for 0.18% of the portfolio, ranked #36.
Peirce Capital Management first reported a position in LLY in Q4 2023 and has held it in 12 quarters since. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Peirce Capital Management held 432 shares of Eli Lilly worth $500K as of Q3 2026.
- Peirce Capital Management bought 29 Eli Lilly shares in Q3 2026, an estimated $34.2K.
- Eli Lilly made up 0.18% of Peirce Capital Management's portfolio in Q3 2026, its #36 holding.
- Peirce Capital Management first reported a position in Eli Lilly in Q4 2023 and has held it in 12 quarters since.
- 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Peirce Capital Management's 13F filing for Q3 2026, filed 19 Oct 2026.